Counterfeit Peptides in the UK: MHRA Raids and How to Spot a Fake

Counterfeit peptides in the UK fall into two groups: fake branded medicines such as pens dressed up as Mounjaro or Wegovy, and unlicensed pre-filled pens containing retatrutide, tirzepatide or other peptides made in improvised facilities with no sterility, identity or purity control. In 2025 the MHRA seized nearly 20 million doses of illegally traded medicines worth around £45 million, including more than 5,000 GLP-1 products, and in October 2025 it dismantled what it described as the first illicit weight-loss pen factory found in the UK. The reliable defence for a researcher is a batch-specific certificate of analysis from a named independent laboratory, checked against the product in hand.

This article sets out what the recent MHRA enforcement actions revealed about how counterfeit and unlicensed peptides are made and sold, why the legal line matters, and a practical checklist for telling a properly tested research peptide from a fake.

What the MHRA raids found

On 22 October 2025 the MHRA Criminal Enforcement Unit, supported by Northamptonshire Police, raided a warehouse on an industrial estate in Northampton. Over a two-day operation officers recovered more than 2,000 unlicensed pre-filled pens containing retatrutide and tirzepatide that were packaged and ready for dispatch, tens of thousands of empty pens, raw chemical ingredients, manufacturing equipment and around £20,000 in cash. The MHRA put the street value of the finished pens at over £250,000 and called it the largest single seizure of trafficked weight-loss medicines recorded by any law enforcement agency worldwide.

Four months later, in February 2026, the same unit worked with Lincolnshire Police, Immigration Enforcement and Lincolnshire Trading Standards to raid a farm near Sleaford and a residential address in Grantham. Almost 2,000 doses of unauthorised weight-loss medicines and other peptide products were seized, again awaiting dispatch to customers, together with manufacturing equipment, suspected pharmaceutical ingredients, packaging and commercial vehicles. Police described the target as an organised crime group, and the MHRA said the operation followed reports of members of the public becoming unwell after buying unregulated injections.

Every illegal product and every piece of manufacturing equipment we seize disrupts these criminal networks and brings us closer to dismantling them entirely.

The annual figures give the scale. In its January 2026 summary of 2025 enforcement, the MHRA reported nearly 20 million doses seized across all categories, the disruption of more than 1,500 websites and social media accounts, and a sharp rise in falsified or unlicensed weight-loss injections, up from a handful in earlier years to several thousand. On 30 December 2025 it also issued a public alert about weight-loss products promoted on social media, warning that products sold illegally online may contain harmful substances or the wrong dose.

Why these cases matter for research peptide buyers

It is important to be precise about what the MHRA acted against. The Northampton and Lincolnshire sites were filling pens for sale to members of the public as weight-loss injections. Under the Human Medicines Regulations 2012, a product presented for treating or preventing a condition, or for altering physiological function, is a medicine, and manufacturing or supplying one without a licence is a criminal offence. Calling something a research chemical does not change that if it is being marketed or sold for people to inject.

Research peptides sit on the other side of that line. Retatrutide, cagrilintide, AOD 9604 and most of the other compounds in a research catalogue have no MHRA marketing authorisation, and they are legal to buy, sell and possess in the UK only as laboratory reagents for research use. Tirzepatide is different again: Mounjaro is an MHRA-licensed medicine, but research-grade tirzepatide is not that medicine and cannot be represented as it. A supplier that markets pens with weight-loss claims, testimonials, or advice on how to use them is not operating as a research supplier, whatever its website says.

How counterfeit peptides are made and sold

The raids revealed a fairly consistent model. Bulk peptide powder of unknown origin is bought in kilogram quantities, weighed out and dissolved in domestic or light-industrial premises, then filled into empty pen cartridges or vials that are bought separately in bulk. There is no clean room, no validated filling process, no endotoxin or sterility testing, and often no analytical confirmation that the powder is what the label says. The product is then sold through social media, messaging apps and disposable websites, frequently with counterfeit branding or with a made-up brand of its own.

The failure modes that follow are predictable. Independent testing of seized and market-sampled products in the UK and elsewhere has found pens that contain a fraction of the labelled amount, pens that contain a different peptide entirely, and pens that contain the right peptide with high levels of impurities, truncated sequences or bacterial endotoxin. Because most of these products are watery, colourless solutions, none of this is visible to the eye.

How to verify a certificate of analysis

A COA is the single most useful document in spotting a fake, but only if you read it properly. Counterfeiters know buyers ask for COAs, so it is common to see a real report copied from another vendor, an old report reused for every batch, or a home-made PDF with a laboratory logo pasted on. Work through the following checks.

1. Match the batch. The lot or batch number on the COA must match the number printed on the pen or vial. A COA without a batch number is not a COA for your product.
2. Identify the laboratory. The report should come from a named, independent analytical lab with a real address and contact details. Calibre batches are tested by Janoshik Analytical; its reports carry a unique report ID that can be checked against the lab's own records.
3. Check the methods. Purity should be measured by HPLC and identity confirmed by mass spectrometry. A purity figure with no chromatogram, or an identity claim with no observed molecular weight, is a red flag.
4. Read the numbers. Look for purity above 99% and an observed mass that matches the theoretical mass of the peptide. Quantity should be reported as peptide content, not gross weight.
5. Check the date. A report dated years before the product was made cannot describe that batch.
6. Compare with the published COA. A reputable supplier publishes its COAs on its own website. Calibre's COA page currently lists Retatrutide 30mg and 40mg, Tirzepatide 60mg, Tesamorelin 20mg and MOTS-c 40mg, and the published report should be identical to the one supplied with the order.

Physical checks on a peptide pen

Appearance cannot confirm purity, but it can rule some products out. A pre-filled research pen from a precision manufacturer should arrive with an intact tamper-evident seal, clear and consistent labelling with the compound name, milligram content and batch number, and a solution that is clear and free of particles. Cloudiness, visible precipitate, a cracked or leaking cartridge, mismatched or smudged labels, and packaging that does not match the supplier's published images are all reasons to stop and query the order.

Lyophilised vials have their own tells. A properly freeze-dried peptide is a compact white cake or fine powder; a shrunken, melted or discoloured plug suggests poor drying or heat exposure, and a vial with no vacuum when the stopper is pierced may have been refilled. Copper peptides such as GHK-Cu should be blue; most others should be white or colourless. Again, these observations are screening tools, not a substitute for the COA.

Checks on the supplier

The MHRA cases share a pattern: anonymous sellers, social-media-only marketing, and an absence of any accountable business behind the product. The inverse of that pattern is a reasonable description of what to look for.

• A UK-based business with a fixed website, a company identity and a named person behind it. Calibre was founded by Scott and can be reached by email at sales@calibre-pens.co.uk as well as via WhatsApp and Telegram.
• Clear research-use-only terms on every product page, with no medicinal claims, testimonials or usage guidance.
• Third-party testing by a named laboratory, with COAs published openly rather than sent on request.
• Consistent product information: the same milligram figures, purity targets and batch numbers across the website, the COA and the label.
• Willingness to answer technical questions about the peptide, the testing method and the pen format before you buy.

What to do if you suspect a fake

If a product fails any of the checks above, do not use it in research and do not pass it on. Keep the packaging, the COA you were given and the order records. Suspected counterfeit or unlicensed medicines can be reported to the MHRA through its Yellow Card scheme, which accepts reports about fake or substandard products as well as adverse reactions, and Trading Standards can be contacted through your local council. Reports from buyers are one of the main ways the enforcement unit builds the cases that lead to raids like those in Northampton and Lincolnshire.

Summary

The counterfeit peptide trade in the UK is now large enough that the MHRA is finding pen factories, not just parcels. The products it seized were unlicensed, untested and sold for human use, which is illegal for any research peptide. For a laboratory buyer the practical protection is the same in every case: a batch-specific certificate of analysis from a named independent lab that matches the lot in your hand, sold by an identifiable UK business that makes no medical claims and gives no usage advice. Anything that cannot meet that standard is not worth the risk to your research.